Care Without Impoverishment

Care Without Impoverishment

Designing universal primary health systems. A comparative synthesis of how public financing, medicine purchasing, primary-care capacity, and accountable delivery can expand access without pushing households into financial hardship.

The Shared WellsOriginal visual study · AI-generated

Research Question

Which combinations of public financing, essential-benefit guarantees, medicine purchasing, primary-care capacity, and workforce allocation expand access while reducing impoverishing health spending?

Publication
Evidence Brief
Published
Pillar
Healthcare
Evidence base
4 primary sources
Review status
Foundation synthesis; not peer reviewed
Executive synthesis

Universal health coverage is not achieved when a service technically exists but remains unaffordable, geographically distant, administratively inaccessible, or dependent on an unreliable medicine supply. The evidence points to a dual obligation: expand effective access to essential services and protect households from the financial consequences of using them.

The most durable reform frame is therefore systemic rather than programmatic. Financing, workforce, medicines, data, facilities, community participation, and accountability have to be designed as one operating model. This brief does not identify a single country template; it identifies functions that any credible universal system must perform.

Findings

What the evidence supports.

Source markers link findings to the evidence below.

01

Coverage gains coexist with exclusion

The global universal-health-coverage service index rose from 54 in 2000 to 71 in 2023, yet an estimated 4.6 billion people still lacked coverage for essential health services in 2023 and 2.1 billion experienced financial hardship from health spending in 2022. Progress in an average index cannot substitute for distributional evidence. [1] [2]

02

Medicine costs are central to financial protection

In three quarters of countries with available data, medicines accounted for at least 55% of out-of-pocket health spending. Benefit design that excludes outpatient medicines can leave the principal household burden untouched even when consultations are publicly covered. [2] [4]

03

The burden is structurally unequal

WHO and the World Bank report that three in four people in the poorest population segment experienced financial hardship from health costs, compared with fewer than one in 25 among the richest. Financial protection should therefore be measured by income group, geography, disability, gender, migration status, and other relevant barriers—not only as a national average. [2]

04

Primary care reform is an operating-system reform

WHO's implementation evidence treats primary health care as coordinated work across governance, financing, workforce, medicines, technology, infrastructure, digital systems, and community participation. Building clinics without securing these connected functions is unlikely to produce reliable access. [3]

Institutional Implications

What this changes in practice.

These are design implications drawn from the synthesis, not claims that one institutional model will fit every jurisdiction.

01

Define the guarantee in lived terms

A public guarantee should specify covered services, medicines, diagnostics, travel or geographic access, waiting-time expectations, language and disability access, and a route to remedy when the guarantee fails.

02

Treat medicine purchasing as public infrastructure

Selection, pooled procurement, price negotiation, supply monitoring, quality assurance, and shortage response should be governed as one essential public function rather than as disconnected transactions.

03

Measure continuity, not enrollment alone

Dashboards should track whether people complete referrals, obtain prescribed medicines, avoid catastrophic costs, and can challenge denials. Enrollment is an input; continuous access without financial harm is the outcome.

Research Programme

What the foundation should test next.

  1. Build a comparable country typology linking financing design, primary-care organization, and financial-protection outcomes without ranking unlike systems on a single score.
  2. Test an essential-medicine affordability and availability basket across urban, rural, and remote settings, including stock-out duration and substitution quality.
  3. Prototype a patient-facing access guarantee with notice, navigation, and appeal standards, then measure whether it reduces abandoned or delayed care.

Method & Limits

How to read this brief.

Method

This rapid evidence brief synthesizes recent global monitoring, implementation guidance, and expert review from the World Health Organization and World Bank. Sources were selected for institutional authority, recency, relevance to system design, and public accessibility. Claims are limited to what the cited sources support; the foundation has not independently reproduced their underlying estimates.

Limitations

Cross-country health expenditure and coverage measures are affected by differences in data quality, benefit definitions, prices, and health-system structure. The evidence supports a set of functions and safeguards, not a universal financing formula. Country design should be co-produced with patients, clinicians, public administrators, and communities facing the greatest barriers.

Source Record

Read the official sources.

  1. [1]

    World Health Organization and World Bank · 5 December 2025

    Global Monitoring Report on Universal Health Coverage 2025

    Global service-coverage and financial-hardship estimates.

  2. [2]

    World Health Organization and World Bank · 6 December 2025

    Most countries make progress towards universal health coverage, but major challenges remain

    Distributional findings and the role of medicine spending.

  3. [3]

    World Health Organization · 15 May 2024

    Implementing the primary health care approach: a primer

    Implementation framework for coordinated primary health care reform.

  4. [4]

    World Health Organization · 5 September 2025

    The selection and use of essential medicines, 2025: executive summary

    Evidence standards for effectiveness, safety, and cost-effectiveness in essential-medicine selection.

Suggested citation: True Tomorrow Foundation (2026). Care Without Impoverishment. Evidence Brief. Reviewed July 17, 2026.

Related reading